Milestone Pharmaceuticals Inc. Contracts & Agreements
42 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (1)
- Human Resources (19)
- Uncategorized (7)
- Royalty Purchase Agreement, dated as of March 27, 2023, by and among the Company and RTW (Filed With SEC on March 31, 2023)
- Note Purchase Agreement, dated as of March 27, 2023, by and among the Company and RTW (Filed With SEC on March 31, 2023)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 29, 2023)
- Consulting Agreement, between the Company and Francis Plat (Filed With SEC on March 29, 2023)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 29, 2023)
- Form of Exchange Warrant (Filed With SEC on March 27, 2023)
- Exchange Agreement, dated as of March 22, 2023, by and among the Company and certain investors party thereto (Filed With SEC on March 27, 2023)
- 2019 Equity Incentive Plan, as amended (Filed With SEC on November 10, 2022)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 24, 2022)
- Employment Agreement, dated February 15, 2022 between David Bharucha, M.D., Ph.D. and Milestone Pharmaceuticals USA, Inc (Filed With SEC on February 16, 2022)
- Form of Pre-Funded Warrants to Purchase Common Shares (Filed With SEC on August 11, 2021)
- License and Collaboration Agreement by and among the Company and Ji Xing Pharmaceuticals, Limited, dated May 15, 2021 (Filed With SEC on August 11, 2021)
- The Non-employee Director Compensation Policy, as amended (Filed With SEC on May 17, 2021)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 29, 2021)
- The Non-employee Director Compensation Policy, as amended (Filed With SEC on November 13, 2020)
- Underwriting Agreement, dated October 22, 2020, by and among the Company, Jefferies LLC and Piper Sandler & Co (Filed With SEC on October 26, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on October 26, 2020)
- Open Market Sale AgreementSM, dated July 29, 2020, by and between Milestone Pharmaceuticals Inc. and Jefferies LLC (Filed With SEC on July 29, 2020)
- Form of Pre-Funded Warrant to Purchase Common Shares (Filed With SEC on July 23, 2020)
- Securities Purchase Agreement dated July 22, 2020 (Filed With SEC on July 23, 2020)
- First Amendment to Amended and Restated Employment Agreement, dated June 4, 2020, between the Company and Joseph Oliveto (Filed With SEC on June 9, 2020)
- First Amendment to Employment Agreement, dated June 4, 2020, between the Company and Amit Hasija (Filed With SEC on June 9, 2020)
- Amending Agreement, dated June 4, 2020, between the Company and Francis Plat (Filed With SEC on June 9, 2020)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 6, 2020)
- Employment Agreement, dated September 9, 2019, between the Company and Amit Hasija (Filed With SEC on September 10, 2019)
- Form of Underwriting Agreement (Filed With SEC on April 29, 2019)
- Form of Common Share Certificate of the Registrant (Filed With SEC on April 29, 2019)
- Amended and Restated Employment Agreement between Joseph Oliveto and Milestone Pharmaceuticals USA, Inc (Filed With SEC on April 29, 2019)
- Amended and Restated Employment Agreement between Philippe Douville and Milestone Pharmaceuticals Inc (Filed With SEC on April 29, 2019)
- Amended and Restated Employment Agreement between Francis Plat and Milestone Pharmaceuticals Inc (Filed With SEC on April 29, 2019)
- Amended and Restated Employment Agreement between Lorenz Muller and Milestone Pharmaceuticals USA, Inc (Filed With SEC on April 29, 2019)
- Employment Agreement between Timothy L. Maness and Milestone Pharmaceuticals USA, Inc (Filed With SEC on April 29, 2019)
- Third Amended and Restated Registration Rights Agreement, by and among the Registrant and certain of its shareholders, dated October 15, 2018 (Filed With SEC on April 12, 2019)
- Third Amended and Restated Stock Option Plan (Filed With SEC on April 12, 2019)
- Form of Award and Grant Notices under the Third Amended and Restated Stock Option Plan (Filed With SEC on April 12, 2019)
- Form of 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
- Form of United States Stock Option Grant Notice and Stock Option Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
- Form of United States Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
- Form of Canadian Stock Option Grant Notice and Option Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
- Form of Canadian Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on April 12, 2019)
- Form of Indemnity Agreement (Filed With SEC on April 12, 2019)
